Co-delivery of GM-CSF and anticancer drugs using a chitosan-based hydrogel system resulted in a synergistic anticancer effect, as tumor-specific CD8+ T cell responses were significantly enhanced (113). This evidence concerns the gene CSF2 and neoplasm.